(For all products, API with EU-GMP, with non-infringing process, and with high quality EDMF/CTD or CoS according to latest EP/ICH/CPMP guidelines.)
| Agomelatine |
Aripiprazole |
Asenapine |
| Bortezomib |
Clopidogrel |
Dabigatran |
| Donepezil |
Entecavir |
Escitalopram |
| Ezogabine |
Febuxostat |
Imatinib |
| Latanoprost |
Levetiracetam |
Losartan |
| Olmesartan |
Oxcarbazepine |
Paroxetine |
| Pioglitazone |
Pregabalin |
Rivaroxaban |
| Sitagliptin |
Solifenacin |
Sunitinib |
| Tadalafil |
Telmisartan |
Vildagliptin |
< New products under CTD preparation by CSI >
| Ambrisentan |
Apprepitant |
Atazanavir |
| Fulvestrant |
Febuxostat |
Lacosamide |
| Telbivudine |
Ticagrelor |
|
